News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
74,163 Results
Type
Article (1944)
Company Profile (2)
Press Release (72211)
Section
Business (25388)
Career Advice (9)
Deals (4561)
Drug Delivery (1)
Drug Development (8168)
FDA (1813)
Job Trends (809)
News (37112)
Policy (3583)
Tag
2027 BioCapital Standard (1)
Academia (100)
Accelerated approval (5)
ADA (2)
Allergies (25)
Alliances (8175)
ALS (22)
Alzheimer's disease (192)
Antibody-drug conjugate (ADC) (128)
Approvals (2004)
Artificial intelligence (40)
ASCO (37)
Autoimmune disease (41)
Automation (2)
Bankruptcy (9)
Best Places to Work (592)
BIO (9)
Biologics (1)
Biosimilars (101)
BioSpace Insights (1)
Biotechnology (5)
Bispecific (2)
Bladder cancer (32)
Brain cancer (8)
Breast cancer (66)
Cancer (693)
Cardiovascular disease (31)
Career advice (10)
CAR-T (18)
CDC (2)
CDMO (9)
Celiac Disease (1)
Cell therapy (65)
Cervical cancer (5)
Clinical research (7804)
Collaboration (358)
Commercialization (6)
Compensation (28)
Complete response letters (7)
COVID-19 (200)
CRISPR (1)
C-suite (113)
Cystic fibrosis (9)
Data (933)
Depression (18)
Dermatology (14)
Diabetes (53)
Diagnostics (657)
Digital health (8)
Drug discovery (46)
Drug pricing (1)
Drug shortages (1)
Duchenne muscular dystrophy (50)
Earnings (8277)
Events (7685)
Executive appointments (80)
FDA (2389)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (172)
Gene editing (7)
Generative AI (1)
Gene therapy (43)
GLP-1 (91)
Government (248)
Grass and pollen (1)
Guidances (41)
Healthcare (1100)
Hematology (14)
HIV (7)
Huntington's disease (3)
IgA nephropathy (27)
Immunology and inflammation (7)
Immuno-oncology (12)
Indications (31)
Infectious disease (228)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (44)
IPO (1641)
Job creations (245)
Job search strategy (10)
JPM (3)
Kidney cancer (2)
Kidney disease (6)
Labor market (1)
Layoffs (6)
Legal (966)
Licensing (15)
Liver cancer (22)
Longevity (3)
Lung cancer (133)
Lung diease (2)
Lymphoma (60)
Machine learning (1)
Manufacturing (156)
Marketing (5)
MASH (19)
Medical device (1178)
Medtech (1199)
Mergers & acquisitions (3138)
Metabolic disorders (129)
mRNA (8)
Multiple sclerosis (28)
NASH (1)
Neurodegenerative disease (39)
Neuropsychiatric disorders (7)
Neuroscience (371)
NextGen: Class of 2026 (218)
Non-profit (64)
Now hiring (1)
Obesity (47)
Opinion (2)
Ovarian cancer (36)
Pain (22)
Pancreatic cancer (33)
Parkinson's disease (51)
Partnered (4)
Patents (82)
Patient recruitment (92)
Patient selection (6)
Peanut (2)
People (5257)
Peptides (1)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2103)
Phase 2 (3306)
Phase 3 (2951)
Pipeline (1488)
Policy (1)
Postmarket research (241)
Preclinical (712)
Press Release (2)
Prostate cancer (29)
Radiopharmaceuticals (29)
Rare diseases (98)
Real estate (609)
Regenerative medicine (1)
Regulatory (3139)
Reports (9)
Research institute (98)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (25)
Series A (37)
Series B (26)
Service/supplier (1)
Sickle cell disease (8)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (425)
Stomach cancer (2)
Substance use disorders (2)
Supply chain (14)
Vaccines (48)
Venture capital (7)
Weight loss (22)
Women's health (9)
Date
Today (16)
Last 7 days (69)
Last 30 days (236)
Last 365 days (2891)
2026 (2209)
2025 (2700)
2024 (3265)
2023 (3823)
2022 (7034)
2021 (6390)
2020 (5888)
2019 (3870)
2018 (3022)
2017 (3565)
2016 (3179)
2015 (4038)
2014 (3033)
2013 (2605)
2012 (2781)
2011 (2907)
2010 (2671)
Location
Africa (89)
Alabama (5)
Arizona (14)
Arkansas (1)
Asia (22422)
Australia (2506)
California (883)
Canada (506)
China (562)
Colorado (5)
Connecticut (29)
Delaware (9)
Europe (13617)
Florida (117)
Georgia (18)
Hawaii (1)
Illinois (48)
India (80)
Indiana (33)
Japan (376)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (137)
Massachusetts (701)
Michigan (9)
Minnesota (40)
Missouri (3)
Nebraska (3)
Nevada (14)
New Hampshire (1)
New Jersey (569)
New York (304)
North Carolina (133)
Northern California (382)
Ohio (7)
Oregon (1)
Pennsylvania (165)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (434)
Tennessee (6)
Texas (67)
United States (3424)
Utah (35)
Vermont (1)
Virginia (68)
Washington D.C. (3)
Washington State (64)
Wisconsin (8)
Wyoming (1)
74,163 Results for "lupin ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspension
September 28, 2026
·
2 min read
Press Releases
Lupin Announces Approval from U.S. FDA for Pitolisant Tablets
August 17, 2026
·
1 min read
Press Releases
Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP
September 6, 2026
·
1 min read
Press Releases
Lupin Launches Azilsartan Medoxomil Tablets in the United States
June 18, 2026
·
1 min read
Press Releases
Lupin Named Among World’s Most Sustainable Companies by TIME and Statista
July 6, 2026
·
2 min read
Press Releases
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
July 30, 2026
·
1 min read
Press Releases
Lupin Announces the Approval of Diazepam Injection, USP in the United States
July 28, 2026
·
1 min read
Press Releases
Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
June 28, 2026
·
1 min read
Press Releases
Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy
July 21, 2026
·
3 min read
Press Releases
Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States
August 10, 2026
·
1 min read
1 of 7,417
Next
